vortioxetine

Known as: 1-(2-(2,4-dimethylphenylsulfanyl)phenyl)piperazine, 4-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazin-1-ium, vortioxetine cation 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
This multicenter, randomized, double-blind, placebo-controlled, active-referenced (duloxetine 60 mg), parallel-group study… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2014
Highly Cited
2014
The efficacy of vortioxetine 10 and 20 mg/d vs. placebo on cognitive function and depression in adults with recurrent moderate-to… (More)
  • figure 2
  • figure 1
Is this relevant?
2014
2014
This study assessed the efficacy, tolerability and safety of vortioxetine versus placebo in adults with recurrent major… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2014
2014
Depressed patients suffer from cognitive dysfunction, including memory deficits. Acute serotonin (5-HT) depletion impairs memory… (More)
Is this relevant?
2013
2013
BACKGROUND AND OBJECTIVE The identification and quantification of potential drug-drug interactions is important for avoiding or… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2013
2013
The serotonergic system plays an important role in cognitive functions via various 5-HT receptors. Vortioxetine (Lu AA21004) in… (More)
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
2013
2013
Vortioxetine (Lu AA21004) is a multi-modal antidepressant in clinical development for the treatment of major depressive disorder… (More)
Is this relevant?
2013
2013
Vortioxetine (Lu AA21004) is an investigational novel antidepressant with multimodal activity that functions as a 5-HT3, 5-HT7… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2013
2013
Vortioxetine is an orally administered small molecule developed by Lundbeck A/S for the once-daily treatment of major depressive… (More)
Is this relevant?
2012
2012
OBJECTIVE The primary objective of this study was to evaluate the safety and tolerability of the investigational drug… (More)
Is this relevant?